Driving research of Myalgic Encephalomyelitis / Chronic Fatigue Syndrome (ME / CFS),
Post Treatment Lyme Disease Syndrome (PTLDS), Fibromyalgia and Long Covid.

Donate
Sign Up
Main Menu

Extended Big Data Study in Families

Study AIM

Beginning in 2016, the aim of this study was to extend the Severely ill Patient Study (SIPS) and conduct a comprehensive “Big Data” analysis on ME/CFS patients and their families. 

LEAD INVESTIGATORS
  • Fereshteh K. Jahaniani, PhD
  • Michael P. Snyder, PhD
  • Ronald W. Davis, PhD
Updates and Potential

Coming soon…

STUDY HYPOTHESIS AND DESCRIPTION

The rationale of this study is that by using the unaffected family members as a control, the differences observed in the ME/CFS patients will be more specific to the disease and less related to differences in genetics, environment, and diet.

OBJECTIVES

The rationale of this study is that by using the unaffected family members as a control, the differences observed in the ME/CFS patients will be more specific to the disease and less related to differences in genetics, environment, and diet.

Almost as extensive as the SIPS study, blood from each patient is being used to examine the following:

  • Genome
  • Gene expression
  • Metabolomics
  • Proteomics
  • Cytokines

By comparing patients to healthy blood relatives, we are more likely to understand what genes cause or contribute to the development of ME/CFS. This data will also be integrated with the SIPS data.

Other links you might be interested in:
Frequently Asked Questions (FAQ)
History of ME / CFS
Facebook Twitter Youtube Instagram Linkedin
OMF is a non-profit 501(c)(3) organization
(EIN# 26-4712664). All donations are tax-deductible to the full extent allowed by law.

Open Medicine Foundation®
29302 Laro Drive,  Agoura Hills, CA 91301 USA
Phone: 650-242-8669 

Contact Us
PRIVACY POLICY | MEDICAL DISCLAIMER

Copyright © 2023 Open Medicine Foundation. All Rights Reserved.

Myalgic Encephalomyelitis / Chronic Fatigue Syndrome (ME / CFS) Post Treatment Lyme Disease Syndrome (PTLDS), Fibromyalgia Leading Research. Delivering Hope.Open Medicine Foundation®

What are the advantages of giving from your Donor Advised Fund (DAF)?

  • Your gifts to your donor advised fund entitle you to an immediate income tax deduction at the time of contribution.
  • You avoid capital gains tax on appreciated assets you place in your donor advised fund.
  • Your fund’s investment gains accumulate tax free.
  • Funds are distributed to Open Medicine Foundation in your name and immediately put to use to support our worldwide research efforts.

How do I make a donation through my DAF?

Just click on the DAF widget below. It is simple and convenient to find your fund among the over 900 funds in our system.

Still can’t find your fund? 

  • Request a grant distribution through your Donor Advised Fund sponsor
  • Be sure to use OMF’s EIN #26-4712664
  • You can also designate OMF as a beneficiary for your Donor Advised Fund
  • Questions? Give us a call at 650-242-8669 
 
Donate